Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 24172225)

1.

Involvement of Fcα/μR (CD351) in autoantibody production.

Yoshizawa Y, Honda S, Shibuya A.

Mol Immunol. 2014 Feb;57(2):216-9. doi: 10.1016/j.molimm.2013.10.002. Epub 2013 Oct 27.

PMID:
24172225
2.

Increased serum IgA in Fcα/μR-deficient mice on the (129 x C57BL/6) F1 genetic background.

Kurita N, Honda S, Shibuya A.

Mol Immunol. 2015 Feb;63(2):367-72. doi: 10.1016/j.molimm.2014.09.008. Epub 2014 Oct 2.

PMID:
25282043
3.

Molecular characteristics of IgA and IgM Fc binding to the Fcalpha/muR.

Cho Y, Usui K, Honda S, Tahara-Hanaoka S, Shibuya K, Shibuya A.

Biochem Biophys Res Commun. 2006 Jun 23;345(1):474-8. Epub 2006 Apr 27.

PMID:
16681999
4.

Unusual biochemical features and follicular dendritic cell expression of human Fcalpha/mu receptor.

Kikuno K, Kang DW, Tahara K, Torii I, Kubagawa HM, Ho KJ, Baudino L, Nishizaki N, Shibuya A, Kubagawa H.

Eur J Immunol. 2007 Dec;37(12):3540-50.

5.

Obesity-associated autoantibody production requires AIM to retain the immunoglobulin M immune complex on follicular dendritic cells.

Arai S, Maehara N, Iwamura Y, Honda S, Nakashima K, Kai T, Ogishi M, Morita K, Kurokawa J, Mori M, Motoi Y, Miyake K, Matsuhashi N, Yamamura K, Ohara O, Shibuya A, Wakeland EK, Li QZ, Miyazaki T.

Cell Rep. 2013 Apr 25;3(4):1187-98. doi: 10.1016/j.celrep.2013.03.006. Epub 2013 Apr 4.

6.

Enhanced humoral immune responses against T-independent antigens in Fc alpha/muR-deficient mice.

Honda S, Kurita N, Miyamoto A, Cho Y, Usui K, Takeshita K, Takahashi S, Yasui T, Kikutani H, Kinoshita T, Fujita T, Tahara-Hanaoka S, Shibuya K, Shibuya A.

Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11230-5. doi: 10.1073/pnas.0809917106. Epub 2009 Jun 19.

7.

AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4.

White CA, Seth Hawkins J, Pone EJ, Yu ES, Al-Qahtani A, Mai T, Zan H, Casali P.

Autoimmunity. 2011 Dec;44(8):585-98. doi: 10.3109/08916934.2011.577128. Epub 2011 May 18. Erratum in: Autoimmunity. 2011 Dec;44(8):664.

8.

Induction of autoantibodies in normal mice by injection of nucleobindin and natural occurrence of antibodies against nucleobindin in autoimmune MRL/lpr/lpr mice.

Kanai Y, Takeda O, Miura K, Amagai M, Kaneko T, Kubota T, Kanai Y, Tanuma S, Kurosawa Y.

Immunol Lett. 1995 Feb;45(1-2):35-42.

PMID:
7622185
9.

Identification of the Fcalpha/muR isoform specifically expressed in the kidney tubules.

Kurita N, Honda S, Usui K, Shimizu Y, Miyamoto A, Tahara-Hanaoka S, Shibuya K, Shibuya A.

Mol Immunol. 2009 Feb;46(4):749-53. doi: 10.1016/j.molimm.2008.10.002. Epub 2008 Nov 21.

PMID:
19027165
10.

Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.

Mannoor K, Matejuk A, Xu Y, Beardall M, Chen C.

J Immunol. 2012 Apr 15;188(8):3628-38. doi: 10.4049/jimmunol.1102859. Epub 2012 Mar 9.

11.

FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.

Yajima K, Nakamura A, Sugahara A, Takai T.

Eur J Immunol. 2003 Apr;33(4):1020-9.

PMID:
12672068
12.

Structural requirements for the interaction of human IgM and IgA with the human Fcalpha/mu receptor.

Ghumra A, Shi J, Mcintosh RS, Rasmussen IB, Braathen R, Johansen FE, Sandlie I, Mongini PK, Areschoug T, Lindahl G, Lewis MJ, Woof JM, Pleass RJ.

Eur J Immunol. 2009 Apr;39(4):1147-56. doi: 10.1002/eji.200839184.

13.

Characterization of IgA and IgM binding and internalization by surface-expressed human Fcα/μ receptor.

Yoo EM, Trinh KR, Lim H, Wims LA, Morrison SL.

Mol Immunol. 2011 Sep;48(15-16):1818-26. doi: 10.1016/j.molimm.2011.05.011. Epub 2011 May 31.

PMID:
21632111
14.

Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus.

Liang B, Kashgarian MJ, Sharpe AH, Mamula MJ.

J Immunol. 2000 Sep 15;165(6):3436-43.

15.

Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus.

Satoh M, Weintraub JP, Yoshida H, Shaheen VM, Richards HB, Shaw M, Reeves WH.

J Immunol. 2000 Jul 15;165(2):1036-43.

16.

Suppression of autoimmune disease and of massive lymphadenopathy in MRL/Mp-lpr/lpr mice lacking tyrosine kinase Fyn (p59fyn).

Takahashi T, Yagi T, Kakinuma S, Kurokawa A, Okada T, Takatsu K, Aizawa S, Katagiri T.

J Immunol. 1997 Sep 1;159(5):2532-41.

PMID:
9278347
17.

Molecular characterization of the dimer formation of Fcα/μ receptor (CD351).

Takagaki K, Satoh K, Honda S, Shibuya A.

Mol Immunol. 2013 Nov;56(1-2):23-7. doi: 10.1016/j.molimm.2013.04.003. Epub 2013 May 9.

PMID:
23665380
18.

Monoclonal IgM rheumatoid factors derived from arthritic MRL/Mp-lpr/lpr mice.

Theofilopoulos AN, Balderas RS, Hang L, Dixon FJ.

J Exp Med. 1983 Sep 1;158(3):901-19.

19.

Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses.

Ma J, Xu J, Madaio MP, Peng Q, Zhang J, Grewal IS, Flavell RA, Craft J.

J Immunol. 1996 Jul 1;157(1):417-26.

PMID:
8683147
20.

DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo.

Lenert P, Yasuda K, Busconi L, Nelson P, Fleenor C, Ratnabalasuriar RS, Nagy PL, Ashman RF, Rifkin IR, Marshak-Rothstein A.

Arthritis Res Ther. 2009;11(3):R79. doi: 10.1186/ar2710. Epub 2009 May 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk